Clinical Trials
3 trialsNCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT03983954 2025-11-28
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
NeoTX Therapeutics Ltd.
Phase 1 Active not recruiting
NCT04115254 2025-11-13
Stereotactic Magnetic Resonance Guided Radiation Therapy
Dana-Farber Cancer Institute
Phase NA Recruiting